Does the media prefer XRAY or COO?

In the previous week, Cooper Companies had 12 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 25 mentions for Cooper Companies and 13 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.42 beat DENTSPLY SIRONA's score of 0.34 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 1 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Cooper Companies 4 Very Positive mention(s) 7 Positive mention(s) 8 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MMSI or XRAY?

In the previous week, DENTSPLY SIRONA had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.71 beat DENTSPLY SIRONA's score of 0.34 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DENTSPLY SIRONA 1 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to NVST or XRAY?

In the previous week, DENTSPLY SIRONA had 4 more articles in the media than Envista. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 9 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 0.34 beat Envista's score of -0.11 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 1 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer XRAY or BLCO?

In the previous week, Bausch + Lomb had 5 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 18 mentions for Bausch + Lomb and 13 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 0.34 beat Bausch + Lomb's score of 0.23 indicating that DENTSPLY SIRONA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 1 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Bausch + Lomb 1 Very Positive mention(s) 1 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer XRAY or ICUI?

In the previous week, DENTSPLY SIRONA had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.13 beat DENTSPLY SIRONA's score of 0.34 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 1 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral ICU Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DENTSPLY SIRONA (XRAY) Competitors

$8.51 -0.02 (-0.23%)

Closing price 04:00 PM Eastern

Extended Trading

$8.60 +0.09 (+1.06%)

As of 07:50 PM Eastern

Compare

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

Should you buy DENTSPLY SIRONA stock or one of its competitors? DENTSPLY SIRONA's main competitors and comparable companies include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), Bausch + Lomb (BLCO), and ICU Medical (ICUI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does DENTSPLY SIRONA compare to Cooper Companies?

DENTSPLY SIRONA (NASDAQ:XRAY) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

DENTSPLY SIRONA has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

DENTSPLY SIRONA currently has a consensus price target of $13.17, suggesting a potential upside of 54.36%. Cooper Companies has a consensus price target of $68.60, suggesting a potential upside of 23.51%. Given DENTSPLY SIRONA's higher possible upside, research analysts clearly believe DENTSPLY SIRONA is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cooper Companies	2 Sell rating(s)	13 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.11

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.47	-$598M	-$2.75	N/A
Cooper Companies	$4.09B	2.58	$374.90M	$2.93	18.96

Cooper Companies has a net margin of 13.46% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Cooper Companies	13.46%	10.90%	7.24%

In the previous week, Cooper Companies had 12 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 25 mentions for Cooper Companies and 13 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.42 beat DENTSPLY SIRONA's score of 0.34 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	1 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cooper Companies	4 Very Positive mention(s)	7 Positive mention(s)	8 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cooper Companies beats DENTSPLY SIRONA on 12 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Merit Medical Systems has a net margin of 9.22% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Merit Medical Systems currently has a consensus price target of $100.00, indicating a potential upside of 11.42%. DENTSPLY SIRONA has a consensus price target of $13.17, indicating a potential upside of 54.36%. Given DENTSPLY SIRONA's higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
DENTSPLY SIRONA	3 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.54	$128.49M	$2.42	37.09
DENTSPLY SIRONA	$3.64B	0.47	-$598M	-$2.75	N/A

In the previous week, DENTSPLY SIRONA had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.71 beat DENTSPLY SIRONA's score of 0.34 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	1 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Envista has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Envista presently has a consensus price target of $29.64, suggesting a potential upside of 30.61%. DENTSPLY SIRONA has a consensus price target of $13.17, suggesting a potential upside of 54.36%. Given DENTSPLY SIRONA's higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.41
DENTSPLY SIRONA	3 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envista has a net margin of 3.33% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.34	$47M	$0.58	39.13
DENTSPLY SIRONA	$3.64B	0.47	-$598M	-$2.75	N/A

In the previous week, DENTSPLY SIRONA had 4 more articles in the media than Envista. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 9 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 0.34 beat Envista's score of -0.11 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	1 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Bausch + Lomb?

DENTSPLY SIRONA (NASDAQ:XRAY) and Bausch + Lomb (NYSE:BLCO) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

DENTSPLY SIRONA presently has a consensus target price of $13.17, suggesting a potential upside of 54.36%. Bausch + Lomb has a consensus target price of $19.46, suggesting a potential upside of 21.24%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.47

DENTSPLY SIRONA has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bausch + Lomb has a net margin of -3.21% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Bausch + Lomb	-3.21%	4.14%	1.93%

Bausch + Lomb has higher revenue and earnings than DENTSPLY SIRONA. Bausch + Lomb is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.47	-$598M	-$2.75	N/A
Bausch + Lomb	$5.10B	1.12	-$360M	-$0.48	N/A

In the previous week, Bausch + Lomb had 5 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 18 mentions for Bausch + Lomb and 13 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 0.34 beat Bausch + Lomb's score of 0.23 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	1 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Bausch + Lomb	1 Very Positive mention(s)	1 Positive mention(s)	14 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Bausch + Lomb beats DENTSPLY SIRONA on 10 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

DENTSPLY SIRONA currently has a consensus target price of $13.17, indicating a potential upside of 54.36%. ICU Medical has a consensus target price of $192.80, indicating a potential upside of 17.63%. Given DENTSPLY SIRONA's higher probable upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

DENTSPLY SIRONA has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ICU Medical has a net margin of 1.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
ICU Medical	1.39%	7.91%	4.17%

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.47	-$598M	-$2.75	N/A
ICU Medical	$2.23B	1.84	$730K	$1.18	138.91

In the previous week, DENTSPLY SIRONA had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.13 beat DENTSPLY SIRONA's score of 0.34 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	1 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
ICU Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.70B	$5.58B	$7.27B	$13.21B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	5.97	19.85	193.11	18.97
Price / Sales	0.46	67.33	561.77	81.05
Price / Cash	1.42	32.25	77.16	53.04
Price / Book	1.27	5.86	10.71	6.03
Net Income	-$598M	$146.14M	$3.50B	$380.34M
7 Day Performance	-0.12%	-1.23%	-3.18%	-3.04%
1 Month Performance	-18.64%	-3.00%	-6.61%	-5.16%
1 Year Performance	-30.30%	1.97%	3.69%	-2.48%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.0283 of 5 stars	$8.51 -0.2%	$13.17 +54.7%	-27.9%	$1.70B	$3.68B	5.97	14,000
COO Cooper Companies	4.6821 of 5 stars	$56.77 -0.2%	$71.47 +25.9%	-18.8%	$10.80B	$4.24B	19.38	15,000
MMSI Merit Medical Systems	3.5196 of 5 stars	$87.14 +2.1%	$100.00 +14.8%	+13.6%	$5.10B	$1.52B	36.01	7,500	Analyst Upgrade
NVST Envista	3.5412 of 5 stars	$23.39 -0.3%	$29.79 +27.4%	+18.8%	$3.77B	$2.86B	40.32	12,000
BLCO Bausch + Lomb	4.6034 of 5 stars	$17.21 +0.6%	$19.15 +11.3%	+11.9%	$6.11B	$5.10B	N/A	13,000	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Which has more volatility and risk, XRAY or COO?

Do analysts rate XRAY or COO?

Do insiders & institutionals hold more shares of XRAY or COO?

Which has stronger earnings and valuation, XRAY or COO?

Is XRAY or COO more profitable?

Does the media prefer XRAY or COO?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Is MMSI or XRAY more profitable?

Do analysts recommend MMSI or XRAY?

Which has preferable earnings & valuation, MMSI or XRAY?

Does the media refer more to MMSI or XRAY?

Do institutionals and insiders believe in MMSI or XRAY?

Which has more risk & volatility, MMSI or XRAY?

Summary

How does DENTSPLY SIRONA compare to Envista?

Do institutionals & insiders hold more shares of NVST or XRAY?

Which has more risk and volatility, NVST or XRAY?

Do analysts recommend NVST or XRAY?

Is NVST or XRAY more profitable?

Which has stronger valuation and earnings, NVST or XRAY?

Does the media refer more to NVST or XRAY?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Do analysts prefer XRAY or BLCO?

Which has more volatility & risk, XRAY or BLCO?

Do institutionals and insiders hold more shares of XRAY or BLCO?

Is XRAY or BLCO more profitable?

Which has higher valuation and earnings, XRAY or BLCO?

Does the media prefer XRAY or BLCO?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Do analysts rate XRAY or ICUI?

Which has more risk and volatility, XRAY or ICUI?

Do insiders and institutionals have more ownership in XRAY or ICUI?

Is XRAY or ICUI more profitable?

Which has preferable valuation & earnings, XRAY or ICUI?

Does the media prefer XRAY or ICUI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools